Mohamad Basem Alkassab, Fareeha Ajmal Shaikh, Caroline Hamm, Mir Munir A. Rahim
{"title":"Adaptive NKG2C+ NK cells in cytomegalovirus seropositive individuals predominantly lack NKR-P1A receptor expression","authors":"Mohamad Basem Alkassab, Fareeha Ajmal Shaikh, Caroline Hamm, Mir Munir A. Rahim","doi":"10.1002/eji.202451562","DOIUrl":null,"url":null,"abstract":"<p>The impact of cytomegalovirus (CMV) infection in shaping natural killer (NK) cell receptor (NKR) repertoire highlights the importance of NKRs in immunity against CMV. NKR-P1A (CD161) is an inhibitory NKR, whose expression is lost during CMV infection, but its role in NK cell responses during CMV infection is not known. Here, we show selective expansion of adaptive NKG2C<sup>+</sup> NK cells lacking NKR-P1A receptor (NKR-P1A<sup>‒</sup>) due to their increased activation and proliferation compared with NKR-P1A<sup>+</sup> NK cells in CMV-infected individuals. <i>In vitro</i> stimulation of PBMCs showed similar inherent proliferative capacity in both NKR-P1A<sup>+</sup> versus NKR-P1A<sup>‒</sup> NK cells in steady state and upregulation, but not loss of NKR-P1A receptor expression, in sorted NK cells. Furthermore, CMV infection induced differential gene expression profiles in NKR-P1A<sup>+</sup> versus NKR-P1A<sup>‒</sup> NK cells, and only NKR-P1A<sup>‒</sup> NK cells exhibited transcriptome signatures associated with adaptive NK cells in CMV-infected individuals. This study further highlights the impact of CMV infection in shaping NK cell receptor repertoire and exclusion of NK cells that express the NKR-P1A receptor from the adaptive NKG2C<sup>+</sup> NK cell population that expands during CMV infection.</p>","PeriodicalId":165,"journal":{"name":"European Journal of Immunology","volume":"55 5","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202451562","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/eji.202451562","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The impact of cytomegalovirus (CMV) infection in shaping natural killer (NK) cell receptor (NKR) repertoire highlights the importance of NKRs in immunity against CMV. NKR-P1A (CD161) is an inhibitory NKR, whose expression is lost during CMV infection, but its role in NK cell responses during CMV infection is not known. Here, we show selective expansion of adaptive NKG2C+ NK cells lacking NKR-P1A receptor (NKR-P1A‒) due to their increased activation and proliferation compared with NKR-P1A+ NK cells in CMV-infected individuals. In vitro stimulation of PBMCs showed similar inherent proliferative capacity in both NKR-P1A+ versus NKR-P1A‒ NK cells in steady state and upregulation, but not loss of NKR-P1A receptor expression, in sorted NK cells. Furthermore, CMV infection induced differential gene expression profiles in NKR-P1A+ versus NKR-P1A‒ NK cells, and only NKR-P1A‒ NK cells exhibited transcriptome signatures associated with adaptive NK cells in CMV-infected individuals. This study further highlights the impact of CMV infection in shaping NK cell receptor repertoire and exclusion of NK cells that express the NKR-P1A receptor from the adaptive NKG2C+ NK cell population that expands during CMV infection.
期刊介绍:
The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more. Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.